Julie Callanan
Psychiatry · Hyannis, MANPI 1992730089
Payments from drug & device makers
Across 364 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$1K
- Otsuka America Pharmaceutical, Inc.$966
- Alkermes, Inc.$934
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$886
- Johnson & Johnson$836
- AbbVie$798
- plus $3K from 12 others
What the payments were for
- Food & beverage$8,17497%
- Education$2623%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 72 | $1,095 |
| Otsuka America Pharmaceutical, Inc. | 34 | $966 |
| Alkermes, Inc. | 32 | $934 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $886 |
| Johnson & Johnson | 32 | $836 |
| AbbVie(2 entities) | 47 | $798 |
| E.r. Squibb & Sons, L.L.C. | 22 | $555 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $546 |
| Sunovion Pharmaceuticals Inc. | 23 | $544 |
| Corium, LLC | 13 | $419 |
| Teva Pharmaceuticals USA, Inc. | 6 | $343 |
| Ironshore Pharmaceuticals Inc. | 7 | $233 |
| Vanda Pharmaceuticals Inc. | 4 | $119 |
| Avanir Pharmaceuticals, Inc. | 3 | $58 |
| Sage Therapeutics, LLC | 2 | $41 |
| Shire North American Group Inc | 2 | $40 |
| Eisai Inc. | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$932
- REXULTI$250
- COBENFY$136
- CAPLYTA$125
- Jornay PM 20mg capsules (Bottle of 100)$104
How this compares
$8,436 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wellbutrin XlBupropion Hcl | 12 | $70,745 |
| RexultiBrexpiprazole | 35 | $61,986 |
| CaplytaLumateperone Tosylate | 26 | $55,851 |
| Invega SustennaPaliperidone Palmitate | 14 | $37,033 |
| AuvelityDextromethorphan Hbr/Bupropion | 18 | $21,208 |
| VraylarCariprazine Hcl | 12 | $16,418 |
| BelsomraSuvorexant | 18 | $10,593 |
| Lurasidone Hcl | 24 | $9,635 |
| VyvanseLisdexamfetamine Dimesylate | 18 | $7,777 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,550 |
| Methylphenidate ErMethylphenidate Hcl | 22 | $4,496 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 28 | $3,778 |
| Chlorpromazine Hcl | 13 | $2,154 |
| Trazodone Hcl | 97 | $2,048 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 41 | $1,781 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $966 | $61,98635 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $886 | $55,85126 claims |
| Johnson & JohnsonInvega Sustenna | $836 | $37,03314 claims |
| AbbVieVraylar | $798 | $16,41812 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $546 | $14,32730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,431 psychiatry providers in Massachusetts.
Other psychiatry in Hyannis
- Lee CohenBoston$7M
- Dyanna DomiliciBoston$5.8M
- Arkadiy StolyarBelmont$3.3M
- Maurizio FavaBoston$2.8M
- Marc ShayAmesbury$1.7M
- Martha StarkNewton$1.6M
- Hadine JoffeBoston$1.5M
- Malini NairWinchester$1M
- Xiaoduo FanWorcester$950K
- Anthony RothschildWorcester$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.